Clinical Trial Update: A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial to evaluate long-term safety of finerenone in children and young adults with heart failure and left ventricular systolic dysfunction; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Left Ventricular Systolic Dysfunction

Drugs mentioned

• Kerendia (finerenone)

Snippet

Sponsor: Bayer | Conditions: Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric) | Phase 3 | Status: NOT_YET_RECRUITING